Dr Raden Mas Jeffri Ismail is a medical Oncologist in Jerudong Park Medical Centre in 2016. He is currently the Deputy Head of Department of Medical Oncology and Palliative Care Medicine.

He trained in South West Ireland  where he was an essential part of the cancer services serving the counties of Cork and Kerry from 2002 to 2016. He has interest in cancers of the breast, gynaecology, colorectal, lymphoma, and interests in aspects of palliative medicine and genetics. He had been involved in Advisory for Joint SEA Advisory Board Meeting for uterine cancer (September 2021 by virtual meeting) and reviewer for Journal of Gastrointestinal Cancer articles (2018-2019). 

Dr R M Jeffri believes in the need to incorporate a holistic approach in treating patient, taking into account patient care and family perspective into their cancer care pathway and weighing the pros and cons of tailored oncology care. The best care pathway may be achieved by good communication and trust between patient and family.   

Qualifications

• EUROPEAN SOCIETY MEDICAL ONCOLOGY 2013
• MB BCH ( NUI) 1999
• Bachelor in Med Sciences  1999
• Bachelor in Obstetrics  (NUI).
• BSc Anatomy 1996 (NUI).

Board Certifications and Affiliations

• European Society of Medical Oncologist  since 2006
• American Society of Medical Oncologist  since 2008

Participation in Trials

• Retrospective Review of Treatment Patterns for patients with clear cell Renal Cell Carcinoma (ReCCTPOR Study). 2013. ICORG (the All Ireland Cooperative Oncology Research Group) Study CRA D001LIE01.
• ICORG Biomarkers of Trastuzumab Resistance in Her 2-neu Positive Breast Cancer( ICORG 06-22) in 2012.
• Are We Meeting the needs of patients with Advanced Breast Cancer in Ireland?: A Nationwide Study (ICORG 13-01). 
• SWOG S1007: A Phase III Randomised Clinical Trial of Standard Adjuvant Endocrine Therapy  +/- Chemotherapy in Patients with 1-3 Positive Nodes, Hormone Receptor Positive and Her2-Negative Breast Cancer with Recurrence core (RS) of 25 or less: SWOG S1007/ICORG 12-01. Via Cork University Hospital. Using Oncotype Dx Scoring in node positive patients. Published in 2021
• Epoetin beta (Neoreocorman) once weekly in patients on chemotherapy with anaemia : 2006 – 2007.
• Irish Pancreatic Cancer study (PANCAN 2008).
• Retrospective Audit of RCC Treatment (Ireland) :-clinical audit of RCC diagnosis,progression, treatment and outcome (2009 – 2013)